Dissecting the molecular basis of organ of Corti development: Where are we now?

被引:29
|
作者
Fritzsch, Bernd [1 ]
Jahan, Israt [1 ]
Pan, Ning [1 ]
Kersigo, Jennifer [1 ]
Duncan, Jeremy [1 ]
Kopecky, Benjamin [1 ]
机构
[1] Univ Iowa, Dept Biol, Coll Liberal Arts & Sci, Iowa City, IA 52242 USA
关键词
INNER-EAR DEVELOPMENT; HAIR CELL-DIFFERENTIATION; SENSORY EPITHELIA; GENE-EXPRESSION; NULL MICE; MAMMALIAN COCHLEA; SUPPORTING CELLS; MORPHOGENESIS; PAX2; SPECIFICATION;
D O I
10.1016/j.heares.2011.01.007
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
This review summarizes recent progress in our understanding of the molecular basis of cochlear duct growth, specification of the organ of Corti, and differentiation of the different types of hair cells. Studies of multiple mutations suggest that developing hair cells are involved in stretching the organ of Corti through convergent extension movements. However, Atoh1 null mutants have only undifferentiated and dying organ of Corti precursors but show a near normal extension of the cochlear duct, implying that organ of Corti precursor cells can equally drive this process. Some factors influence cochlear duct growth by regulating the cell cycle and proliferation. Shortened cell cycle and premature cell cycle exit can lead to a shorter organ of Corti with multiple rows of hair cells (e.g., Foxg1 null mice). Other genes affect the initial formation of a cochlear duct with or without affecting the organ of Corti. Such observations are consistent with evolutionary data that suggest some developmental uncoupling of cochlear duct from organ of Corti formation. Positioning the organ of Corti requires multiple genes expressed in the organ of Corti and the flanking region. Several candidate factors have emerged but how they cooperate to specify the organ of Corti and the topology of hair cells remains unclear. Atoh1 is required for differentiation of all hair cells, but regulation of inner versus outer hair cell differentiation is still unidentified. In summary, the emerging molecular complexity of organ of Corti development demands further study before a rational approach towards regeneration of unique types of hair cells in specific positions is possible. (C) 2011 Elsevier BM. All rights reserved.
引用
收藏
页码:16 / 26
页数:11
相关论文
共 50 条
  • [1] Molecular Pathology in Therapeutics: Where are We Now, and Where are We Going?
    Harrison, David J.
    Faratian, Dana
    CURRENT DRUG TARGETS, 2012, 13 (12) : 1473 - 1474
  • [2] HIV and Solid Organ Transplantation: Where Are we Now
    Jean Botha
    June Fabian
    Harriet Etheredge
    Francesca Conradie
    Caroline T. Tiemessen
    Current HIV/AIDS Reports, 2019, 16 : 404 - 413
  • [3] HIV and Solid Organ Transplantation: Where Are we Now
    Botha, Jean
    Fabian, June
    Etheredge, Harriet
    Conradie, Francesca
    Tiemessen, Caroline T.
    CURRENT HIV/AIDS REPORTS, 2019, 16 (05) : 404 - 413
  • [4] On the development of coaching: where are we now?
    van Nieuwerburgh, Christian
    COACHING-AN INTERNATIONAL JOURNAL OF THEORY RESEARCH AND PRACTICE, 2019, 12 (01) : 1 - 2
  • [5] Phenotypic and molecular basis for genetic variation in jelly palms (Butia sp.): where are we now and where are we headed to?
    Cidon, Camila Fritzen
    Turchetto-Zolet, Andreia Carina
    Bajay, Miklos Maximiliano
    Zucchi, Maria Imaculada
    Konzen, Eneas Ricardo
    GENETICS AND MOLECULAR BIOLOGY, 2023, 46 (03)
  • [6] Molecular pathology in the cancer clinic - where are we now and where are we headed?
    Guillen, A.
    Smallwood, K.
    Killick, D. R.
    JOURNAL OF SMALL ANIMAL PRACTICE, 2021, 62 (07) : 507 - 520
  • [7] AI molecular catalysis: where are we now?
    Tan, Zhenzhi
    Yang, Qi
    Luo, Sanzhong
    ORGANIC CHEMISTRY FRONTIERS, 2025,
  • [8] Angiogenesis inhibitors in clinical development; where are we now and where are we going?
    Eskens, FALM
    BRITISH JOURNAL OF CANCER, 2004, 90 (01) : 1 - 7
  • [9] Angiogenesis inhibitors in clinical development; where are we now and where are we going?
    F A L M Eskens
    British Journal of Cancer, 2004, 90 : 1 - 7
  • [10] COVERAGE WITH EVIDENCE DEVELOPMENT: WHERE ARE WE NOW?
    Zeitler, Emily
    Gilstrap, Lauren
    Slotwiner, David
    Al-Khatib, Sana
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 3010 - 3010